Yu-Ling Tsai Selected Research

Yu-Ling Tsai Research Topics

Disease

7	Neoplasms (Cancer) 06/2022 - 06/2010
3	Inflammation (Inflammations) 01/2019 - 10/2016
2	Urinary Bladder Neoplasms (Bladder Cancer) 05/2022 - 02/2022
2	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 09/2020
2	Fibrosis (Cirrhosis) 01/2020 - 07/2017
2	Colonic Neoplasms (Colon Cancer) 10/2012 - 06/2010
1	Adenocarcinoma of Lung 06/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2022
1	Lung Neoplasms (Lung Cancer) 06/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 10/2021
1	Chronic Renal Insufficiency 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Lupus Nephritis 01/2021
1	Carcinogenesis 09/2020
1	Glioma (Gliomas) 09/2020
1	Ureteral Obstruction 01/2020
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2017
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 08/2014
1	Proteinuria 08/2014
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2009
1	Tic Disorders (Tic Disorder) 05/2009
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 05/2009
1	Infections 05/2009
1	Myocarditis (Carditis) 05/2009

Drug/Important Bio-Agent (IBA)

3	Bile Acids and Salts (Bile Acids)IBA 06/2022 - 10/2021
3	InflammasomesIBA 01/2021 - 01/2017
3	CytokinesIBA 01/2020 - 10/2016
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2022 - 05/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022 - 10/2021
2	Messenger RNA (mRNA)IBA 05/2022 - 09/2020
2	fatty acid-binding protein 6IBA 02/2022 - 10/2021
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2021 - 06/2010
2	Temozolomide (Temodar)FDA LinkGeneric 10/2021 - 09/2020
1	LipidsIBA 06/2022
1	CarcinogensIBA 06/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2022
1	Proteins (Proteins, Gene)FDA Link 05/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2022
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 05/2022
1	Cisplatin (Platino)FDA LinkGeneric 02/2022
1	Saline SolutionIBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 10/2021
1	benzamideIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	NF-kappa B (NF-kB)IBA 09/2020
1	Therapeutic UsesIBA 01/2020
1	ginsenoside M1IBA 01/2020
1	Proline (L-Proline)FDA Link 10/2016
1	Alanine (L-Alanine)FDA Link 10/2016
1	Phosphotransferases (Kinase)IBA 10/2016
1	AntioxidantsIBA 08/2014
1	Dinoprostone (PGE2)FDA Link 08/2014
1	osthol (osthole)IBA 08/2014
1	Ethanol (Ethyl Alcohol)IBA 10/2012
1	Caspase 9IBA 10/2012
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2012
1	chicoric acidIBA 10/2012
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2012
1	CateninsIBA 10/2012
1	Arginine (L-Arginine)FDA Link 06/2010
1	Angiogenic ProteinsIBA 06/2010
1	tyramine-deoxysorbitolIBA 05/2009

Therapy/Procedure

1	Aftercare (After-Treatment) 05/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Radiotherapy 01/2022
1	Therapeutics 01/2019